SiTaxa M 50/1000 Tablet

SiTaxa M 50/1000 Tablet is a combination anti-diabetic medication containing Sitagliptin and Metformin. Sitagliptin is a DPP-4 inhibitor that increases incretin hormone activity, stimulating insulin release and reducing glucose production after meals. Metformin, a biguanide, decreases hepatic glucose production and improves insulin sensitivity.
This combination is used in adults with Type 2 Diabetes Mellitus to control blood sugar levels when diet, exercise, or monotherapy is insufficient.


Uses:

  • Controls high blood sugar in Type 2 diabetes

  • Reduces post-meal glucose spikes

  • Improves insulin sensitivity

  • Helps prevent diabetes-related complications


Dosage:

  • Usually one tablet twice daily, or as prescribed by the doctor

  • Take with meals to reduce gastrointestinal discomfort


How to Use:

  • Swallow the tablet whole with water

  • Take at the same times every day

  • Follow a proper diet and exercise routine


Precautions:

  • Not suitable for Type 1 diabetes or diabetic ketoacidosis

  • Use cautiously in patients with kidney or liver disease

  • Inform doctor if there is a history of pancreatitis

  • Consult doctor if pregnant or breastfeeding


Side Effects:

  • Nausea, vomiting, or diarrhea

  • Stomach upset or abdominal discomfort

  • Headache

  • Low blood sugar (hypoglycemia) when combined with other anti-diabetic drugs

  • Rare: allergic reactions

SiTaxa M 50mg/500mg Tablet

SiTaxa M 50mg/500mg Tablet is a combination anti-diabetic medication containing Sitagliptin and Metformin. Sitagliptin is a DPP-4 inhibitor that enhances incretin hormone activity, increasing insulin release and reducing glucose production after meals. Metformin, a biguanide, works by decreasing glucose production in the liver and improving insulin sensitivity.
This combination helps control blood sugar levels in adults with Type 2 Diabetes Mellitus, especially when diet and exercise alone are insufficient.


Uses:

  • Manages Type 2 diabetes

  • Reduces high blood sugar levels after meals

  • Improves insulin sensitivity

  • Helps prevent diabetes-related complications


Dosage:

  • Typically one tablet twice daily, or as prescribed by the doctor

  • Take with meals to reduce gastrointestinal side effects


How to Use:

  • Swallow the tablet whole with water

  • Take at the same times each day for consistent blood sugar control

  • Continue prescribed diet and exercise


Precautions:

  • Not for Type 1 diabetes or diabetic ketoacidosis

  • Use with caution in patients with kidney or liver issues

  • Inform doctor if history of pancreatitis exists

  • Consult doctor if pregnant or breastfeeding


Side Effects:

  • Nausea, vomiting, or diarrhea

  • Stomach discomfort

  • Headache

  • Low blood sugar (especially if combined with other anti-diabetic drugs)

  • Rare: allergic reactions

Sitaxa M XR 100+1000 Tablet

Sitaxa M XR 100+1000 Tablet is an extended-release combination anti-diabetic medicine containing Sitagliptin and Metformin. Sitagliptin is a DPP-4 inhibitor that enhances incretin hormone activity, stimulating insulin secretion after meals and reducing glucose production. Metformin, a biguanide, decreases hepatic glucose production and improves insulin sensitivity.
The extended-release (ER) formulation ensures gradual release of metformin, reducing gastrointestinal side effects and providing sustained blood sugar control throughout the day. It is indicated for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy is insufficient.


Uses:

  • Controls high blood sugar in Type 2 diabetes

  • Reduces post-meal glucose spikes

  • Improves insulin sensitivity

  • Helps prevent diabetes-related complications


Dosage:

  • Usually one tablet once daily, or as prescribed by the doctor

  • Take with meals to minimize gastrointestinal discomfort


How to Use:

  • Swallow the tablet whole with water; do not crush or chew

  • Take at the same time every day

  • Continue prescribed diet and exercise routine


Precautions:

  • Not for Type 1 diabetes or diabetic ketoacidosis

  • Use cautiously in patients with kidney or liver disease

  • Inform doctor if there is a history of pancreatitis

  • Consult a doctor if pregnant or breastfeeding


Side Effects:

  • Nausea, vomiting, diarrhea, or stomach upset

  • Headache

  • Low blood sugar (hypoglycemia) when combined with other anti-diabetic drugs

  • Rare: allergic reactions

SiTaxa M XR 100+500 Tablet

SiTaxa M XR 100+500 Tablet is an extended-release combination anti-diabetic medication containing Sitagliptin and Metformin. Sitagliptin, a DPP-4 inhibitor, enhances incretin hormone activity, increasing insulin secretion after meals and reducing glucose production. Metformin decreases hepatic glucose production and improves insulin sensitivity.
The extended-release (ER) formulation allows gradual release of metformin, improving blood sugar control and minimizing gastrointestinal side effects. It is prescribed for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy alone is insufficient.


Uses:

  • Controls high blood sugar in Type 2 diabetes

  • Reduces post-meal glucose spikes

  • Improves insulin sensitivity

  • Helps prevent diabetes-related complications


Dosage:

  • Typically one tablet once daily, or as directed by the doctor

  • Take with meals to reduce gastrointestinal discomfort


How to Use:

  • Swallow the tablet whole with water; do not crush or chew

  • Take at the same time each day for consistent blood sugar control

  • Maintain prescribed diet and exercise routine


Precautions:

  • Not suitable for Type 1 diabetes or diabetic ketoacidosis

  • Use cautiously in patients with kidney or liver issues

  • Inform doctor if history of pancreatitis exists

  • Consult a doctor if pregnant or breastfeeding


Side Effects:

  • Nausea, vomiting, diarrhea, or stomach discomfort

  • Headache

  • Low blood sugar (hypoglycemia) when combined with other anti-diabetic drugs

  • Rare: allergic reactions

SiTaxa M XR 50+500 Tablet ER

SiTaxa M XR 50+500 Tablet ER is an extended-release combination anti-diabetic medication containing Sitagliptin and Metformin. Sitagliptin is a DPP-4 inhibitor that increases incretin hormone activity, enhancing insulin secretion and reducing post-meal glucose production. Metformin, a biguanide, decreases liver glucose production and improves insulin sensitivity.
The extended-release (ER) formulation ensures gradual release of metformin, reducing gastrointestinal side effects and providing better blood sugar control throughout the day. It is indicated for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy is insufficient.


Uses:

  • Manages Type 2 diabetes

  • Reduces high blood sugar levels, especially after meals

  • Improves insulin sensitivity

  • Helps prevent diabetes-related complications


Dosage:

  • Usually one tablet once daily, or as prescribed by the doctor

  • Take with meals to minimize gastrointestinal discomfort


How to Use:

  • Swallow the tablet whole with water; do not crush or chew

  • Take at the same time each day

  • Follow a proper diet and exercise regimen


Precautions:

  • Not for Type 1 diabetes or diabetic ketoacidosis

  • Use cautiously in kidney or liver disease

  • Inform doctor if history of pancreatitis

  • Consult a doctor if pregnant or breastfeeding


Side Effects:

  • Nausea, vomiting, diarrhea, or abdominal discomfort

  • Headache

  • Low blood sugar (hypoglycemia) if used with other anti-diabetic drugs

  • Rare: allergic reactions

Sitazit 100mg Tablet

Sitazit 100mg Tablet contains Sitagliptin 100mg, an oral antidiabetic medicine belonging to the class of DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). It helps control blood sugar levels in type 2 diabetes mellitus by increasing the levels of incretin hormones, which stimulate insulin release and reduce glucose production in the liver. This ensures better glycemic control without causing significant hypoglycemia.


Uses of Sitazit 100mg Tablet

  • Management of type 2 diabetes mellitus

  • Helps in lowering fasting and post-meal blood glucose

  • Can be used as monotherapy or in combination with other antidiabetic drugs (e.g., metformin, sulfonylureas, SGLT2 inhibitors)

  • Reduces the risk of diabetes-related complications


How to Use

  • Take the tablet once daily or as prescribed by your doctor.

  • Can be taken with or without food.

  • Maintain a balanced diabetic diet and regular exercise routine for maximum benefit.

  • Do not stop the medication without consulting your doctor.


Side Effects

Common:

  • Headache

  • Stomach discomfort

  • Nasopharyngitis (cold-like symptoms)

Rare but serious:

  • Pancreatitis (severe abdominal pain)

  • Allergic reactions – rash, swelling, difficulty breathing

  • Hypoglycemia (when used with other antidiabetics)


Precautions & Warnings

  • Prescription Required – take only under medical guidance.

  • Not recommended in patients with type 1 diabetes or diabetic ketoacidosis.

  • Use with caution in kidney impairment; dose adjustment may be necessary.

  • Inform your doctor if you have a history of pancreatitis or heart disease.

  • Safe use during pregnancy and breastfeeding has not been established.


Conclusion

Sitazit 100mg Tablet (Sitagliptin 100mg) is an effective DPP-4 inhibitor for type 2 diabetes management, helping improve blood sugar control with a low risk of hypoglycemia. When combined with a healthy lifestyle, diet, and exercise, it supports better glycemic control and reduces long-term diabetes-related complications under proper medical supervision.

Sitazit 50mg Tablet

Sitazit 50mg Tablet contains Sitagliptin 50mg, an oral antidiabetic medicine from the class of DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). It works by increasing incretin hormone levels, which stimulate insulin release after meals and reduce glucose production in the liver. This helps maintain better blood sugar control in patients with type 2 diabetes mellitus, while minimizing the risk of low blood sugar (hypoglycemia).


Uses of Sitazit 50mg Tablet

  • Management of type 2 diabetes mellitus

  • Improves fasting and postprandial blood sugar levels

  • Can be used alone or in combination with other antidiabetic agents like metformin, sulfonylureas, or SGLT2 inhibitors

  • Helps reduce the risk of diabetes-related complications such as nerve damage, kidney issues, and heart problems


How to Use

  • Take the tablet once daily or as directed by your doctor.

  • May be taken with or without food.

  • Stick to a healthy diet, exercise, and regular blood sugar monitoring while on treatment.

  • Do not skip or stop medication without medical advice.


Side Effects

Common:

  • Headache

  • Stomach upset or indigestion

  • Nasopharyngitis (cold-like symptoms)

Rare but serious:

  • Pancreatitis (severe abdominal pain)

  • Allergic reactions such as rash, itching, or swelling

  • Low blood sugar (more likely if used with other diabetes medicines)


Precautions & Warnings

  • Prescription Required – use only under medical guidance.

  • Not suitable for type 1 diabetes or diabetic ketoacidosis.

  • Dose adjustment may be needed in kidney problems.

  • Inform your doctor if you have a history of pancreatitis or heart disease.

  • Safety in pregnancy and breastfeeding is not well established – use only if prescribed.


Conclusion

Sitazit 50mg Tablet (Sitagliptin 50mg) is an effective oral DPP-4 inhibitor for controlling blood sugar in type 2 diabetes patients. It helps regulate glucose levels throughout the day, improves overall diabetic control, and lowers the risk of long-term complications when used along with diet, exercise, and regular monitoring under medical supervision.

Sitazit-D 10mg/100mg Tablet

Sitazit-D 10mg/100mg Tablet is a combination antidiabetic medicine containing Dapagliflozin 10mg (an SGLT2 inhibitor) and Sitagliptin 100mg (a DPP-4 inhibitor). Together, they work by different mechanisms to provide better control of type 2 diabetes mellitus:

  • Dapagliflozin lowers blood sugar by preventing glucose reabsorption in the kidneys, leading to glucose elimination through urine.

  • Sitagliptin increases incretin hormone activity, boosting insulin release after meals and reducing glucose production in the liver.

This dual approach helps in better glycemic control, weight management, and reduced risk of diabetes complications.


Uses of Sitazit-D 10mg/100mg Tablet

  • Management of type 2 diabetes mellitus in adults

  • Helps control fasting and postprandial (after-meal) blood glucose levels

  • Provides added benefits in weight reduction

  • May help in lowering the risk of cardiovascular and kidney-related complications in diabetes


How to Use

  • Take the tablet once daily or as prescribed by your doctor.

  • Can be taken with or without food.

  • Maintain a diabetic-friendly diet, exercise, and regular blood sugar monitoring while on treatment.

  • Do not stop the medicine without consulting your doctor.


Side Effects

Common:

  • Increased urination

  • Urinary tract infections

  • Headache

  • Nasopharyngitis (cold-like symptoms)

Less common but serious:

  • Dehydration or low blood pressure

  • Genital infections

  • Pancreatitis (rare but possible)

  • Hypoglycemia (when taken with other antidiabetics)


Precautions & Warnings

  • Prescription Required – use only under medical supervision.

  • Not recommended in patients with type 1 diabetes or diabetic ketoacidosis.

  • Use with caution in those with kidney or liver problems.

  • Stay well hydrated to avoid dehydration.

  • Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.

  • Monitor blood sugar, kidney function, and blood pressure regularly during treatment.


Conclusion

Sitazit-D 10mg/100mg Tablet (Dapagliflozin 10mg + Sitagliptin 100mg) is a powerful dual-action therapy for type 2 diabetes management. By targeting blood sugar through both the kidneys and incretin pathway, it helps patients achieve better glucose control, weight benefits, and long-term protection against complications when combined with a healthy lifestyle and medical supervision.

Sitazit-M 50mg/1000mg Tablet

Sitazit-M 50mg/1000mg Tablet is a dual-therapy antidiabetic medicine designed to treat type 2 diabetes mellitus. It combines:

  • Sitagliptin (50mg): A DPP-4 inhibitor that improves incretin hormone activity, stimulates insulin release after meals, and lowers high blood glucose.

  • Metformin (1000mg): A biguanide that reduces glucose production in the liver and improves insulin sensitivity in muscles, helping the body use sugar more effectively.

Together, they provide superior blood sugar control, reduce HbA1c levels, and help lower the risk of long-term diabetes-related complications.


Uses of Sitazit-M 50mg/1000mg Tablet

  • Management of type 2 diabetes mellitus

  • Control of fasting and postprandial blood glucose levels

  • Reduction in the risk of diabetic complications (kidney, nerve, and eye damage)

  • Improved insulin sensitivity and metabolic control


How to Use

  • Take orally as prescribed by your doctor, usually once or twice daily.

  • Swallow whole with water; do not chew or crush.

  • Always take with meals to reduce stomach upset.

  • Combine with a balanced diet, exercise, and lifestyle changes for best results.


Side Effects

Common:

  • Nausea, diarrhea, stomach upset

  • Headache, dizziness

  • Fatigue, mild weight loss

Serious (rare):

  • Lactic acidosis (serious metabolic condition from metformin – requires urgent care)

  • Pancreatitis (severe abdominal pain)

  • Hypoglycemia (rare, more likely if used with insulin/sulfonylureas)


Precautions & Warnings

  • Prescription Required – take only under medical supervision.

  • Not for type 1 diabetes or diabetic ketoacidosis.

  • Use with caution in patients with kidney, liver, or heart disease.

  • Avoid alcohol to reduce lactic acidosis risk.

  • Pregnant or breastfeeding women should consult their doctor.

  • Regular monitoring of blood sugar, HbA1c, kidney, and liver function is advised.


Conclusion

Sitazit-M 50mg/1000mg Tablet combines Sitagliptin and Metformin to provide effective blood sugar control in type 2 diabetes patients. With dual benefits of incretin enhancement and insulin sensitivity improvement, it helps achieve long-term glycemic balance and prevents serious diabetes-related complications.

Sitazit-M ER 1000 Tablet

Sitazit-M ER 1000 Tablet is a dual combination antidiabetic medicine used for the management of type 2 diabetes mellitus. It contains:

  • Sitagliptin (100mg): A DPP-4 inhibitor that enhances incretin activity, increases insulin release after meals, and lowers glucose production.

  • Metformin (1000mg, Extended-Release): A biguanide that reduces hepatic glucose output and improves the body’s response to insulin.

This combination provides effective blood sugar control, helps in reducing HbA1c levels, and may also support weight stability in patients with type 2 diabetes.


Uses of Sitazit-M ER 1000 Tablet

  • Management of type 2 diabetes mellitus

  • Improves fasting and postprandial blood sugar levels

  • Helps in long-term glycemic control

  • Reduces the risk of diabetes-related complications (kidney, eye, nerve, and heart problems)


How to Use

  • Take the tablet once daily (extended-release) or as directed by your doctor.

  • Swallow whole with water; do not crush or chew.

  • Best taken with meals to reduce gastric side effects.

  • Continue to follow a diabetic-friendly diet, exercise routine, and regular sugar monitoring.


Side Effects

Common:

  • Headache

  • Nausea, stomach upset, diarrhea

  • Upper respiratory tract infection

  • Weakness or fatigue

Serious but rare:

  • Lactic acidosis (linked to metformin, rare but serious)

  • Pancreatitis (severe abdominal pain)

  • Kidney or liver function impairment


Precautions & Warnings

  • Prescription Required – use only under medical supervision.

  • Not for use in type 1 diabetes or diabetic ketoacidosis.

  • Use with caution in patients with kidney, liver, or heart disease.

  • Avoid excessive alcohol while on this medication.

  • Pregnant and breastfeeding women should consult their doctor before use.

  • Regular monitoring of blood sugar, kidney function, and HbA1c is advised.


Conclusion

Sitazit-M ER 1000 Tablet (Sitagliptin + Metformin) is a powerful dual-action therapy for type 2 diabetes mellitus, combining the benefits of DPP-4 inhibition and insulin sensitization. With proper diet, exercise, and medical guidance, it helps maintain stable blood sugar levels and prevents long-term complications of diabetes.

Sitazit-M ER 500 Tablet

Sitazit-M ER 500 Tablet is an oral antidiabetic combination used to manage type 2 diabetes mellitus. It contains:

  • Sitagliptin (100mg): A DPP-4 inhibitor that enhances incretin hormones, boosts insulin release, and lowers blood glucose after meals.

  • Metformin (500mg, Extended-Release): A biguanide that reduces glucose production in the liver and improves the body’s insulin sensitivity.

This dual therapy helps achieve better blood sugar control, reduces HbA1c levels, and lowers the risk of long-term diabetes complications.


Uses of Sitazit-M ER 500 Tablet

  • Control of type 2 diabetes mellitus

  • Improvement in fasting and post-meal glucose levels

  • Helps prevent microvascular (kidney, eye, nerve) and cardiovascular complications

  • Supports long-term glycemic stability


How to Use

  • Take as prescribed by your doctor, usually once daily.

  • Swallow whole with water; do not crush or chew.

  • Best taken with food to minimize stomach upset.

  • Maintain a healthy diet, exercise, and regular glucose monitoring for best results.


Side Effects

Common:

  • Headache, dizziness

  • Nausea, vomiting, diarrhea, stomach discomfort

  • Weakness, fatigue

Serious (rare):

  • Lactic acidosis (linked to metformin, requires immediate medical attention)

  • Pancreatitis (severe abdominal pain)

  • Kidney or liver dysfunction


Precautions & Warnings

  • Prescription Required – use only under medical advice.

  • Not suitable for type 1 diabetes or diabetic ketoacidosis.

  • Caution in patients with kidney, liver, or heart conditions.

  • Avoid alcohol consumption to reduce lactic acidosis risk.

  • Pregnant or breastfeeding women should consult their doctor.

  • Regular monitoring of blood sugar, HbA1c, and kidney function is recommended.


Conclusion

Sitazit-M ER 500 Tablet provides dual-action blood sugar control by combining Sitagliptin and Metformin. It is effective in managing type 2 diabetes, improving overall glycemic control, and preventing long-term complications when combined with a healthy lifestyle.

Sulisent 100mg Tablet

About Sulisent 100mg Tablet:
Sulisent 100mg Tablet contains Canagliflozin, an SGLT2 inhibitor that helps lower blood sugar by blocking glucose reabsorption in the kidneys and promoting its excretion through urine. It is prescribed for patients with type 2 diabetes, often in combination with diet, exercise, and other antidiabetic medications.

How It Works:

  • Canagliflozin (100mg): Inhibits SGLT2 proteins in the kidneys, reducing glucose reabsorption and increasing urinary glucose excretion.

  • Helps lower fasting and postprandial blood glucose levels.

  • May contribute to weight reduction and improved blood pressure as additional benefits.

Uses:

  • Management of type 2 diabetes mellitus

  • Helps reduce HbA1c levels

  • Can be used alone or with other antidiabetic medications

  • Supports weight and cardiovascular risk management in diabetic patients

Directions for Use:

  • Take once daily before the first meal of the day or as prescribed by your doctor.

  • Swallow the tablet whole with water.

  • Maintain a healthy diet, exercise regularly, and monitor blood sugar levels for optimal results.

Side Effects:
Common side effects may include:

  • Urinary tract infections

  • Increased urination

  • Thirst, dizziness, or dehydration

  • Rarely, low blood sugar (hypoglycemia) when combined with other antidiabetic drugs

Seek medical attention if you experience severe dehydration, fainting, urinary problems, or signs of ketoacidosis such as nausea, vomiting, abdominal pain, or rapid breathing.

Precautions:

  • Avoid in patients with type 1 diabetes, severe kidney disease, or a history of diabetic ketoacidosis

  • Monitor kidney function and blood glucose levels regularly

  • Not recommended during pregnancy or breastfeeding unless prescribed

  • Inform your doctor about other medications, especially diuretics or insulin